The Gynecologic Cancer InterGroup (GCIG) sixth Ovarian Cancer Conference on Clinical
Research was held virtually in October, 2021, following published consensus guidelines. The …

A powerful way to discover key genes with causal roles in oncogenesis is to identify
genomic regions that undergo frequent alteration in human cancers. Here we present high-…

MicroRNA (miRNA) expression profiles for lung cancers were examined to investigate
miRNA's involvement in lung carcinogenesis. miRNA microarray analysis identified statistical …

Clear cell carcinoma of the ovary (CCC) is a histologic subtype of epithelial ovarian cancer
with a distinct clinical behavior. There are marked geographic differences in the prevalence …

Clear cell carcinoma of the ovary has distinct biology and clinical behavior. There are significant
geographical and racial differences in the incidence of clear cell carcinoma compared …

Cell cycle arrest at the G1 checkpoint allows completion of critical macromolecular events
prior to S phase. Regulators of the G1 checkpoint include an inhibitor of cyclin-dependent …

Background Data are limited regarding the use of poly(adenosine diphosphate [ADP]–ribose)
polymerase inhibitors, such as veliparib, in combination with chemotherapy followed by …

Purpose: We aimed to find key molecules associated with chemoresistance in ovarian
cancer using gene expression profiling as a screening tool. Experimental Design: Using two …

Introduction Many advances in the understanding of the pathologic and molecular features
of endometrial cancer have occurred since the FIGO staging was last updated in 2009. …

PURPOSE To evaluate the addition of the humanized monoclonal antiprogrammed death
ligand-1 (PD-L1) antibody, atezolizumab, to platinum-based chemotherapy and …